GlobalSpace Technologies zooms on contract with Cadila Healthcare
GlobalSpace Technologies has signed a commercial contract with Cadila Healthcare, agreeing to share the use of its DocExa pro platform with Cadila. Just a month away from the formal launch of DoxExa, associating with Cadila, one of the major Indian pharmaceutical companies, is an important stepping-stone for GlobalSpace to expand its outreach.
DocExa is an artificial intelligence (AI) enabled virtual consultation app developed by GlobalSpace as part of its HealthTech business vertical. This contract will enable DocExa to reach a larger platform and also, to gain substantial market share through Cadila's extensive network. The app allows what is now the need of the hour, with doctors setting up their own personalized virtual consultation clinic to see patients. According to GlobalSpace, the app is highly secure as it is equipped with AS2 advanced levels of encryption, thus eliminating the risk of any leak or sharing of patient information. The app is expected to benefit the masses during such pandemic situations and offer quality and affordable healthcare services to all.
GlobalSpace Technologies also has a contract with Mediapp which is a digital distribution network of pharmaceuticals. By creating a digital healthcare ecosystem, GlobalSpace intends to connect DocExa with Mediapp, allowing for various chemists to directly reach patients and doctors.
GlobalSpace Technologies is a digital, mobility, analytics, AI & Cloud technology company providing integrated health-tech platforms to the healthcare sector. The company has its presence in the Edutech industry with its subsidiary Makebot which is a STEAM education imparting platform for students.
At 11 am on Monday, the stock of GlobalSpace Technologies was trading at Rs 66, up by 8.91 per cent or Rs 5.40 per share. The 52-week high is Rs 74.90 and 52-week low is Rs 44 on BSE.
Cadila Healthcare's stock was witnessed trading at Rs 375, up by 0.20 per cent or Rs 0.75 per share. Its 52-week high is Rs 383.65 and 52-week low is Rs 206.45 on BSE.